• 1. An integrated cathode and solid electrolyte via in situ polymerization with significantly reduced interface resistance?
  Jialiang Yuan,Ran Dong,Yuan Li,Yang Liu,Zhuo Zheng,Yuxia Liu,Yan Sun,Benhe Zhong,Zhenguo Wu,Xiaodong Guo Chem. Commun., 2021,57, 13004-13007
• 2. Alt-proteins: A promising future
• 3. Acetylcholinesterase amperometric detection system based on a cobalt(II) tetraphenylporphyrin-modified electrode
  Analyst, 1996,121, 1123-1126
• 4. An artificial photosynthesis system comprising a covalent triazine framework as an electron relay facilitator for photochemical carbon dioxide reduction?
  Siquan Zhang,Shengyao Wang,Liping Guo,Hao Chen,Bien Tan,Shangbin Jin J. Mater. Chem. C, 2020,8, 192-200
• 5. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535

• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Amino fatty acids
• Solvents and Organic Chemicals Organic Compounds Lipids and lipid-like molecules Fatty Acyls Fatty acids and conjugates Amino fatty acids

Introduction to 2-{1-(dimethylamino)methylcyclohexyl}acetic Acid (CAS No: 792853-77-1)

The compound 2-{1-(dimethylamino)methylcyclohexyl}acetic acid, identified by the CAS registry number 792853-77-1, is a significant molecule in the field of organic chemistry and pharmaceutical research. This compound has garnered attention due to its unique structural properties and potential applications in drug development and material science.

Recent studies have highlighted the importance of dimethylamino-containing cyclohexane derivatives in various biological systems. The presence of the dimethylamino group imparts unique electronic and steric properties to the molecule, making it a promising candidate for bioactive compounds. Researchers have explored its role in modulating enzyme activity and its potential as a lead compound in medicinal chemistry.

The synthesis of 2-{1-(dimethylamino)methylcyclohexyl}acetic acid involves a multi-step process, often utilizing advanced catalytic techniques and stereo-selective reactions. These methods ensure high purity and optimal yields, which are critical for its application in preclinical studies.

In terms of pharmacological applications, this compound has shown promise in targeting specific receptors and pathways associated with chronic diseases such as cancer and neurodegenerative disorders. Preclinical data suggest that it may possess anti-inflammatory and antioxidant properties, further underscoring its therapeutic potential.

The structural versatility of CAS No: 792853-77-1 allows for extensive modifications, enabling researchers to explore a wide range of analogs with varying bioactivities. This flexibility is a key factor in its ongoing investigation as a potential drug candidate.

Moreover, recent advancements in computational chemistry have facilitated the modeling of this compound's interactions with biological targets. These studies provide valuable insights into its mechanism of action and guide further optimization efforts.

In conclusion, 2-{1-(dimethylamino)methylcyclohexyl}acetic acid represents a compelling area of research with significant implications for future therapeutic developments. Its unique chemical properties, combined with cutting-edge research methodologies, position it as a vital molecule in the ongoing quest for innovative medical solutions.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)